A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia
Objectives Acute myeloid leukemia (AML) is one of the common hematological diseases with low survival rates. Studies have highlighted the dysregulated expression of immune-related and exosome-related genes (ERGs) in cancers. Nevertheless, it remains to be determined whether combining these genes hav...
Saved in:
| Main Authors: | Zenghui Fang, Jiali Fu, Xin Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2300855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SRSF12 is a prognostic biomarker involved in immune infiltration in acute myeloid leukemia
by: MengMeng Zhang, et al.
Published: (2024-12-01) -
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
by: Amal Kamal Abdel-Aziz
Published: (2024-11-01) -
Cellular heterogeneity and cytokine signatures in acute myeloid leukemia: A novel prognostic model
by: Jinxia Cao, et al.
Published: (2025-02-01) -
6-month survival of patients with acute myeloid leukemia who received modified chemotherapy at Wahidin Sudirohusodo Hospital
by: Edwinda D. Ratu, et al.
Published: (2024-09-01) -
Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity
by: Can Can, et al.
Published: (2025-01-01)